What If You Had Invested $10K in Company INKT Back in 2021?

Investment Scenario: Let’s go back to 2021. Imagine an investor who invested $10000.00 in MiNK Therapeutics, Inc. (INKT) company stock and held it steadily for 4 years . Instead of chasing short-term gains, the investor chose a long-term approach—holding the shares and reinvesting all dividends at the end of each year to purchase additional INKT stock. This strategy, known as dividend reinvestment, allowed the investment to compound over time, not just through stock price appreciation but also through growing dividend payouts.

What made the real difference was dividends being reinvested and not selling the stock during stock splits. Every dividend was used to purchase additional shares. When Company MiNK Therapeutics, Inc. (INKT) stock split, the investor received additional shares without spending a single additional penny. The magic of compounding work - slowly at first and began to compound impressively.

At the end of 2025, the $10000.00 investment in NASDAQ:INKT would be worth approximately $35293.50 due to stock splits and dividends that have been reinvested, which demonstrates a total gain of $25293.50 and a return on investment (ROI) of 252.94%, as well as an annualized compounded growth rate (CAGR) of around 37.06%. This illustrates the advantages of long-term investing, adhered to a disciplined reinvestment plan, and also illustrates how an initially small investment into a strong, fundamentally sound company (and move good company like MiNK Therapeutics, Inc. (INKT)) can create considerable wealth over the long run.

MiNK Therapeutics, Inc. (INKT) Investment Summary (2021 – 2025)

By 2025, the share price declined to $64.17. This led to a reduction in the investment's value. 

 This performance reflects a Compound Annual Growth Rate (CAGR) of approximately 37.06% — a strong return over the period. 

Yearly Breakdown